Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

Two early-life findings stood out in children who later screened positive for autism risk

13

Aug 2026

Two early-life findings stood out in children who later screened positive for autism risk

Children born very preterm were more likely than term-born children to screen positive for autism risk at age 5 using the Social Communication Questionnaire. Among very preterm children, cerebellar abnormalities at term-equivalent age and moderate-to-severe histologic chorioamnionitis were independently associated with higher autism screening risk, alongside male sex and higher social risk.

Your sleep and stress may be connected in a more complicated way than expected

13

Aug 2026

Your sleep and stress may be connected in a more complicated way than expected

A seven-day intensive longitudinal study of 106 university students found little evidence that higher-than-usual daytime stress predicted poorer sleep that night. In contrast, better-than-usual subjective sleep was followed by lower perceived stress the next day, while objective sleep associations were generally weak and uncertain.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.